Wearable technologies, privacy and intellectual property rights
4 likes4,802 views
The webinar covers the implications of wearable technologies on user privacy and intellectual property rights, highlighting key topics such as data processing, necessary consents, risks associated with device information, and legal protections for these technologies. Discussion points include the processing of personal data, including biometric information, and the complexities of data transfer, especially in remote patient monitoring scenarios. Additional concerns revolve around the potential misuse of confidential information and the internal policies of companies regarding monitoring and data collection.
Wearable technologies, privacy and intellectual property rights
- 1. Webinar Wearable technologies, privacy and IP rights Global Lawyers Association Giulio Coraggio DLA Piper Italy giulio.coraggio@dlapiper.com November 20, 2013
- 2. What is all about? Giulio Coraggio - DLA Piper giulio.coraggio@dlapiper.com 2
- 3. Agenda Processing of users' personal data: data transfers data relating to the holder of the device but also third parties How are wearable technologies protected? What are the possible additional risks? Giulio Coraggio - DLA Piper giulio.coraggio@dlapiper.com 3
- 4. Processing of users' data Which data protection law applies? What consent and authorizations are required? and in the case of biometric data? What security measures shall be adopted? What data can be accessed? Giulio Coraggio - DLA Piper giulio.coraggio@dlapiper.com 4
- 5. Remote patient monitoring system Relationship between hospitals / sponsors / platform providers Purposes of processing Medical treatment, clinical trials, articles etc. What are anonymous data? Issue applies to any sector Giulio Coraggio - DLA Piper giulio.coraggio@dlapiper.com 5
- 6. Cloud projects – transfer of data Giulio Coraggio - DLA Piper giulio.coraggio@dlapiper.com 6
- 7. How are these devices protected? Is the software a medical device? What impact on the growth of the market? Trademark protection of generic terms by technology companies? Giulio Coraggio - DLA Piper giulio.coraggio@dlapiper.com 7
- 8. Additional risks Misuse of confidential information information can be collected and transferred to third parties very easily review of companies' internal policy Monitoring of employees? Collection of sounds/images of third parties Giulio Coraggio - DLA Piper giulio.coraggio@dlapiper.com 8
- 9. Thank you! Giulio Coraggio DLA Piper Italy T +39 02 80 618 619 M +39 334 68 81 147 E giulio.coraggio@dlapiper.com Giulio Coraggio - DLA Piper giulio.coraggio@dlapiper.com 9
Editor's Notes
- #5: deliberaworking party sulle appautorizzazione generale del Garantenotifica al Garante della privacy per profilazione e utilizzo di dati biometrici
- #6: Diabetes - Diabetes management requires control of multiple parameters: blood pressure, weight, and blood glucose. The real-time delivery of blood glucose and blood pressure readings enables immediate alerts for patient and healthcare providers to intervene when needed. There is evidence to show that daily diabetes management involving RPM is just as effective as usual clinic visit every 3 months;Congestive heart failure- A systematic review of the literature on home monitoring for heart failure patients indicates that RPM improves quality of life, shortens duration of stay in hospitals, decreases mortality rate, and reduces costs to the healthcare system;Infertility - A recent study of a remote patient monitoring solution for infertility demonstrated that for appropriately screened patients who had been seeking In-Vitro Fertilization (IVF) treatment, a six-month remote monitoring program had the same pregnancy rate as a cycle of IVF.